Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
718 |
|
Actual shortage: | 20 (3%) | |
Anticipated shortage: | 6 (1%) | |
Avoided shortage: | 88 (12%) | |
Resolved: | 604 (84%) | |
Discontinuation Reports |
235 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 235 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
89 (9%) |
|
Overdue reports |
19 (73%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-HYDROXYUREA | 500MG | CAPSULE | Avoided shortage | 2020-10-14 | 2020-10-20 | 126325 |
MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-01-10 | 2023-03-20 | 180346 |
MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-06-21 | 2023-08-16 | 196061 |
MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-08-16 | 2023-11-06 | 201965 |
MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2024-09-24 | 2024-12-16 | 238425 |
MYLAN-HYDROXYUREA | 500MG | CAPSULE | Avoided shortage | 2025-01-28 | 2025-03-04 | 248755 |
MYLAN-HYDROXYUREA | 500MG | CAPSULE | Anticipated shortage | 2025-03-04 | 2025-04-28 | 251917 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2021-11-17 | 2021-12-21 | 149495 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2022-01-18 | 2022-01-26 | 152983 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Avoided shortage | 2022-02-02 | 2022-02-25 | 154043 |
MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2022-02-23 | 2022-03-10 | 155442 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2022-09-01 | 2022-09-07 | 168381 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2023-06-27 | 2023-11-14 | 196701 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2024-06-11 | 2024-07-09 | 230100 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2024-07-09 | 2024-10-29 | 232575 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2024-11-18 | 2025-01-07 | 243383 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2017-03-10 | 2019-01-18 | 189 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 191 |
MYLAN-INDAPAMIDE | 2.5mg | Tablet | Resolved | 2017-03-10 | 2017-03-31 | 194 |
MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2017-03-23 | 2017-04-04 | 4073 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-PRAVASTATIN | 40MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16032 |
MYLAN-PRAVASTATIN | 20MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16148 |
MYLAN-PREGABALIN | 25MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51561 |
MYLAN-PREGABALIN | 50MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51567 |
MYLAN-PREGABALIN | 75MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51573 |
MYLAN-PREGABALIN | 150MG | CAPSULE | Discontinued | 2018-06-05 | 2018-08-01 | 51582 |
MYLAN-PREGABALIN | 300MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51588 |
MYLAN-QUETIAPINE | 25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6778 |
MYLAN-QUETIAPINE | 100MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6781 |
MYLAN-QUETIAPINE | 200MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6784 |
MYLAN-QUETIAPINE | 300MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6788 |
MYLAN-RABEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16039 |
MYLAN-RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16042 |
MYLAN-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6792 |
MYLAN-RAMIPRIL | 2.5MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6797 |
MYLAN-RAMIPRIL | 5.0MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6801 |
MYLAN-RAMIPRIL | 10MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6805 |
MYLAN-RANITIDINE | 150MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6808 |
MYLAN-RANITIDINE | 300MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6811 |
MYLAN-RISEDRONATE | 150MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16049 |